Difference between revisions of "Part:BBa K1739000"
(One intermediate revision by the same user not shown) | |||
Line 29: | Line 29: | ||
===Part improvement=== | ===Part improvement=== | ||
Team USTC 2016 improve this part to make it shorter and more effective to be utilized now. See the [[Part:BBa_K1739000:Experience|Experience page]] for details. | Team USTC 2016 improve this part to make it shorter and more effective to be utilized now. See the [[Part:BBa_K1739000:Experience|Experience page]] for details. | ||
+ | Team Kent 2016 improved this part by removing the constitutive promoter, allowing the user choice as to which promoter they use. See (Part:[https://parts.igem.org/Part:BBa_K1985012 BBa_K1985012]) for more detail. | ||
===References=== | ===References=== |
Latest revision as of 22:43, 29 October 2016
Sequence coding for amyloid Sup35NM
Sup35 is derived from the yeast prion protein Sup35p and excludes the C-terminal domain. The N-terminal domain allows self-assembly of functional amyloid [1][2].
This BioBrick is an improved version of a previously designed BioBrick (Part:BBa_K401001) from the [http://2010.igem.org/Team:Valencia Valencia 2010 iGEM team] that encoded the Sup35 protein from Saccharomyces cerevisiae. The previously designed BioBrick contained illegal BioBrick restriction sites. Our improved BioBrick has optimized in order to remove these cut sites and we have produced a part compatible with the iGEM part submission standards.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 522
Validation
To validate our plasmid, we analyzed it through a diagnostic double restriction cut, followed by agarose gel electrophoresis. A restriction digest of our plasmid was carried out using EcoRI and PstI. These enzymes cleave pSBIC3 at 2029bp, with our insert being 780bp. By comparing the sizes of our inserts to the Invitrogen 1kB DNA Marker, we found that our fragments were the correct sizes.
Function Validation of the Sup35NM sequence was performed on (BBa_K1739002) by diagnostic Congo Red plate assay and AFM imaging that demonstrated the presence of amyloid by formation of red colonies.
Part improvement
Team USTC 2016 improve this part to make it shorter and more effective to be utilized now. See the Experience page for details. Team Kent 2016 improved this part by removing the constitutive promoter, allowing the user choice as to which promoter they use. See (Part:BBa_K1985012) for more detail.
References
[1] Frederick, K., Debelouchina, G., Kayatekin, C., Dorminy, T., Jacavone, A., Griffin, R. and Lindquist, S. (2014). Distinct Prion Strains Are Defined by Amyloid Core Structure and Chaperone Binding Site Dynamics. Chemistry & Biology, 21(2), pp.295-305.
[2] Glover, J., Kowal, A., Schirmer, E., Patino, M., Liu, J. and Lindquist, S. (1997). Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI+], a Heritable Prion-like Factor of S. cerevisiae. Cell, 89(5), pp.811-819.